Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients
Conditions: Onchocerciasis, Ocular; Loiasis Interventions: Drug: Moxidectin 2 MG Oral Tablet; Drug: Ivermectin 3Mg Tab; Drug: Placebo oral tablet Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials